359 related articles for article (PubMed ID: 23788656)
21. Cl transport in complemented CF bronchial epithelial cells correlates with CFTR mRNA expression levels.
Illek B; Maurisse R; Wahler L; Kunzelmann K; Fischer H; Gruenert DC
Cell Physiol Biochem; 2008; 22(1-4):57-68. PubMed ID: 18769032
[TBL] [Abstract][Full Text] [Related]
22. Discovery of novel potent ΔF508-CFTR correctors that target the nucleotide binding domain.
Odolczyk N; Fritsch J; Norez C; Servel N; da Cunha MF; Bitam S; Kupniewska A; Wiszniewski L; Colas J; Tarnowski K; Tondelier D; Roldan A; Saussereau EL; Melin-Heschel P; Wieczorek G; Lukacs GL; Dadlez M; Faure G; Herrmann H; Ollero M; Becq F; Zielenkiewicz P; Edelman A
EMBO Mol Med; 2013 Oct; 5(10):1484-501. PubMed ID: 23982976
[TBL] [Abstract][Full Text] [Related]
23. The dual phosphodiesterase 3/4 inhibitor RPL554 stimulates rare class III and IV CFTR mutants.
Turner MJ; Luo Y; Thomas DY; Hanrahan JW
Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L908-L920. PubMed ID: 32159371
[TBL] [Abstract][Full Text] [Related]
24. Dehydrocostuslactone, a sesquiterpene lactone activates wild-type and ΔF508 mutant CFTR chloride channel.
Wang X; Zhang YF; Yu B; Yang S; Luan J; Liu X; Yang H
J Asian Nat Prod Res; 2013; 15(8):855-66. PubMed ID: 23799322
[TBL] [Abstract][Full Text] [Related]
25. Cystic fibrosis transmembrane conductance regulator (CFTR) activity in nasal epithelial cells from cystic fibrosis patients with severe genotypes.
Andersson C; Dragomir A; Hjelte L; Roomans GM
Clin Sci (Lond); 2002 Oct; 103(4):417-24. PubMed ID: 12241542
[TBL] [Abstract][Full Text] [Related]
26. Cellular differentiation is required for cAMP but not Ca(2+)-dependent Cl- secretion in colonic epithelial cells expressing high levels of cystic fibrosis transmembrane conductance regulator.
Morris AP; Cunningham SA; Benos DJ; Frizzell RA
J Biol Chem; 1992 Mar; 267(8):5575-83. PubMed ID: 1372005
[TBL] [Abstract][Full Text] [Related]
27. A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTR[delta]F508.
deCarvalho AC; Ndi CP; Tsopmo A; Tane P; Ayafor J; Connolly JD; Teem JL
Mol Med; 2002 Feb; 8(2):75-87. PubMed ID: 12080183
[TBL] [Abstract][Full Text] [Related]
28. Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis.
Cholon DM; Quinney NL; Fulcher ML; Esther CR; Das J; Dokholyan NV; Randell SH; Boucher RC; Gentzsch M
Sci Transl Med; 2014 Jul; 6(246):246ra96. PubMed ID: 25101886
[TBL] [Abstract][Full Text] [Related]
29. Targeting autophagy as a novel strategy for facilitating the therapeutic action of potentiators on ΔF508 cystic fibrosis transmembrane conductance regulator.
Luciani A; Villella VR; Esposito S; Gavina M; Russo I; Silano M; Guido S; Pettoello-Mantovani M; Carnuccio R; Scholte B; De Matteis A; Maiuri MC; Raia V; Luini A; Kroemer G; Maiuri L
Autophagy; 2012 Nov; 8(11):1657-72. PubMed ID: 22874563
[TBL] [Abstract][Full Text] [Related]
30. Antihypertensive 1,4-dihydropyridines as correctors of the cystic fibrosis transmembrane conductance regulator channel gating defect caused by cystic fibrosis mutations.
Pedemonte N; Diena T; Caci E; Nieddu E; Mazzei M; Ravazzolo R; Zegarra-Moran O; Galietta LJ
Mol Pharmacol; 2005 Dec; 68(6):1736-46. PubMed ID: 16150931
[TBL] [Abstract][Full Text] [Related]
31. Potentiation of mutant CFTR Cl- channel currents by the naturally occurring stilbene compound resveratrol.
Yu B; Zhang Y; Sui Y; Yang S; Luan J; Wang X; Ma T; Yang H
Pharmazie; 2013 Nov; 68(11):877-81. PubMed ID: 24380236
[TBL] [Abstract][Full Text] [Related]
32. Resveratrol and ivacaftor are additive G551D CFTR-channel potentiators: therapeutic implications for cystic fibrosis sinus disease.
Cho DY; Zhang S; Lazrak A; Grayson JW; Peña Garcia JA; Skinner DF; Lim DJ; Mackey C; Banks C; Matalon S; Woodworth BA
Int Forum Allergy Rhinol; 2019 Jan; 9(1):100-105. PubMed ID: 30152192
[TBL] [Abstract][Full Text] [Related]
33. Function and regulation of TRPM7, as well as intracellular magnesium content, are altered in cells expressing ΔF508-CFTR and G551D-CFTR.
Huguet F; Calvez ML; Benz N; Le Hir S; Mignen O; Buscaglia P; Horgen FD; Férec C; Kerbiriou M; Trouvé P
Cell Mol Life Sci; 2016 Sep; 73(17):3351-73. PubMed ID: 26874684
[TBL] [Abstract][Full Text] [Related]
34. Expression of cystic fibrosis transmembrane conductance regulator in a model epithelium.
Sheppard DN; Carson MR; Ostedgaard LS; Denning GM; Welsh MJ
Am J Physiol; 1994 Apr; 266(4 Pt 1):L405-13. PubMed ID: 7513963
[TBL] [Abstract][Full Text] [Related]
35. Nanomolar affinity small molecule correctors of defective Delta F508-CFTR chloride channel gating.
Yang H; Shelat AA; Guy RK; Gopinath VS; Ma T; Du K; Lukacs GL; Taddei A; Folli C; Pedemonte N; Galietta LJ; Verkman AS
J Biol Chem; 2003 Sep; 278(37):35079-85. PubMed ID: 12832418
[TBL] [Abstract][Full Text] [Related]
36. Defective function of the cystic fibrosis-causing missense mutation G551D is recovered by genistein.
Illek B; Zhang L; Lewis NC; Moss RB; Dong JY; Fischer H
Am J Physiol; 1999 Oct; 277(4):C833-9. PubMed ID: 10516113
[TBL] [Abstract][Full Text] [Related]
37. Evidence against the rescue of defective DeltaF508-CFTR cellular processing by curcumin in cell culture and mouse models.
Song Y; Sonawane ND; Salinas D; Qian L; Pedemonte N; Galietta LJ; Verkman AS
J Biol Chem; 2004 Sep; 279(39):40629-33. PubMed ID: 15280357
[TBL] [Abstract][Full Text] [Related]
38. Phenylglycine and sulfonamide correctors of defective delta F508 and G551D cystic fibrosis transmembrane conductance regulator chloride-channel gating.
Pedemonte N; Sonawane ND; Taddei A; Hu J; Zegarra-Moran O; Suen YF; Robins LI; Dicus CW; Willenbring D; Nantz MH; Kurth MJ; Galietta LJ; Verkman AS
Mol Pharmacol; 2005 May; 67(5):1797-807. PubMed ID: 15722457
[TBL] [Abstract][Full Text] [Related]
39. [Butyl-p-hydroxybenzoate stimulates cystic fibrosis transmembrane conductance regulator Cl- transport].
Ge H; Hou TT; Sun JJ; Yang H
Yao Xue Xue Bao; 2009 Jan; 44(1):32-7. PubMed ID: 19350818
[TBL] [Abstract][Full Text] [Related]
40. Both CFTR and outwardly rectifying chloride channels contribute to cAMP-stimulated whole cell chloride currents.
Schwiebert EM; Flotte T; Cutting GR; Guggino WB
Am J Physiol; 1994 May; 266(5 Pt 1):C1464-77. PubMed ID: 7515570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
